{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:11:37Z","timestamp":1715386297159},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.2169\/internalmedicine.9218-21","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:09:20Z","timestamp":1653948560000},"page":"3301-3308","source":"Crossref","is-referenced-by-count":0,"title":["Microsatellite Instability-high-positive Cancer of Unknown Primary Origin with a Long-term Survival after Surgery Alone"],"prefix":"10.2169","volume":"61","author":[{"given":"Kai","family":"Korekawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hachinohe City Hospital, Japan"},{"name":"Division of Gastroenterology, Tohoku University Graduates School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kunimitsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hachinohe City Hospital, Japan"},{"name":"Division of Surgery, Tohoku University Graduates School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rento","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hachinohe City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet 379: 1428-1435, 2012.","DOI":"10.1016\/S0140-6736(11)61178-1"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Muir C. Cancer of unknown primary site. Cancer 75: 353-356, 1995.","DOI":"10.1002\/1097-0142(19950101)75:1+<353::AID-CNCR2820751317>3.0.CO;2-P"},{"key":"3","unstructured":"3. Ettinger DS, Varadhachary GR, Bowles DW, et al. NCCN clinical practice guidelines in oncology. Occult primary (cancer of unknown primary [CUP]) version 2 J Natl Compr Carc Netw 12: 969-974, 2019."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pavlidis N. Cancer of unknown primary: biological and clinical characteristics. Ann Oncol 14: iii11-iii18, 2003.","DOI":"10.1093\/annonc\/mdg742"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations. APMIS 111: 1089-1094, 2003.","DOI":"10.1111\/j.1600-0463.2003.apm1111203.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist 12: 418-425, 2007.","DOI":"10.1634\/theoncologist.12-4-418"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rades D, Kuhnel G, Wildfang L, B\u00f6rner AR, Schmoll HJ, Knapp W. Localized disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 12: 1606-1609, 2001.","DOI":"10.1023\/A:1013107732572"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bitran JD, Ultmann JE. Malignancies of undetermined primary origin. Dis Mon 38: 213-260, 1992.","DOI":"10.1016\/0011-5029(92)90019-L"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hewitt MJ, Anderson K, Hall GD, et al. Women with peritoneal carcinomatosis of unknown origin: efficacy of image-guided biopsy to determine site-specific diagnosis. BJOG 114: 46-50, 2007.","DOI":"10.1111\/j.1471-0528.2006.01176.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Didolkar MS, Fanous N, Elias EG, Moore RH. Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg 186: 625-630, 1977.","DOI":"10.1097\/00000658-197711000-00014"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Aaltonen LA, Peltom\u00e4ki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993.","DOI":"10.1126\/science.8484121"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Miyakura Y, Sugano K, Konishi F, et al. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis. Genes Chromosomes Cancer 36: 17-25, 2003.","DOI":"10.1002\/gcc.10134"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540, 1994.","DOI":"10.1038\/ng0894-536"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci 96: 206-211, 2005.","DOI":"10.1111\/j.1349-7006.2005.00035.x"},{"key":"15","unstructured":"15. Marabelle A, Le DT, Ascierto PA, et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 38: 1-10, 2020."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Le DT, Kim TW, Van Cutsem E, et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol 38: 11-19, 2020.","DOI":"10.1200\/JCO.19.02107"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tanizaki J, Yonemori K, Akiyoshi K, et al. Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary. Ann Oncol 33: 216-226, 2022.","DOI":"10.1016\/j.annonc.2021.11.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kimura A, Ueta T, Suzuki K, Minagi S, Takeuchi T. A case of intra-peritoneal lymph node metastasis of unknown primary cancer. J Jpn Surg Assoc 66: 1757-1761, 2005 (in Japanese).","DOI":"10.3919\/jjsa.66.1757"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hisamori S, Okabe H, Yoshizawa A, Sakai Y. A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy. Int J Clin Oncol 15: 493-496, 2010.","DOI":"10.1007\/s10147-010-0058-5"},{"key":"20","unstructured":"20. Yamada M, Gotoh S, Minagawa T. Experience of long term survival in a case with surgery for cancer metastasis to brain and mediastinal lymph node from unknown primary site. Kyobu Geka (Jpn J Thorac Surg) 64: 570-573, 2011 (in Japanese)."},{"key":"21","unstructured":"21. Eisaku I, Shigeki W, Yuki F, Masahiro I, Katsuhiko Y. A case of long-term survival without recurrence from an unknown primary carcinoma after resection of lymph node metastasis. J Gastroenterol 111: 1990-1996, 2004 (in Japanese)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Matsuzawa H, Aoki J, Munezo S, et al. Unknown primary cancer with ileocecal lymph node metastasis - a case report. J Jpn Surg Assoc 80: 1162-1167, 2019 (in Japanese).","DOI":"10.3919\/jjsa.80.1162"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th ed. Esophagus 14: 1-65, 2017.","DOI":"10.1007\/s10388-016-0556-2"},{"key":"24","unstructured":"24. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 15th ed. Kanehara, Tokyo, 2017 (in Japanese)."},{"key":"25","unstructured":"25. Japanese Society of Hepato-Biliary-Pancreatic Surgery. General Rules for Clinical and Pathological Studies on Cancer of the Biliary Tract. 7th ed. Kanehara, Tokyo, 2021 (in Japanese)."},{"key":"26","unstructured":"26. Japan Pancreas Society. General Rules for the Study of Pancreatic Cancer. 7th ed. Kanehara, Tokyo, 2020 (in Japanese)."},{"key":"27","unstructured":"27. Liver Cancer Study Group of Japan. General Rules for Clinical and Pathological Studies on Cancer of Primary Liver Cancer. 6th ed. Kanehara, Tokyo, 2019 (in Japanese)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/21\/61_9218-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:30:33Z","timestamp":1715315433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/21\/61_9218-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9218-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"9218-21"}}